DS
Therapeutic Areas
Can Fite Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Piclidenoson (CF101) | Moderate-to-Severe Plaque Psoriasis | Phase 3 |
| Namodenoson (CF102) | Non-Alcoholic Steatohepatitis (NASH) | Phase 2b |
Leadership Team at Can Fite Biopharma
DP
Dr. Pnina Fishman
Chief Executive Officer & Chief Scientific Officer
MF
Motti Farbstein
Chief Financial Officer
DM
Dr. Michael Silverman
Chief Medical Officer
DI
Dr. Irene Klinger
Vice President of Business Development
PI
Prof. Itamar Raz
Chairman of the Board
DG
Dr. Guy Regev
Director
IF
Ilana Fogel
Director